Analyst Ratings for Bristol-Myers Squibb Co. (BMY)
BMY Rating Summary
BMY Price Target Summary
- Highest: $75.00 (Barclays)
- Lowest: $40.00 (Morgan Stanley)
- Average: $61.40
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$61.40 (+7.5%)
* Over Last 12-Mos
Rating Score: 2.9 / 10
Percentile Rank: 24%
Avg. $ Target:
$61.40 (+7.5%)
* Over Last 12-Mos
Rating Score: 2.9 / 10
Percentile Rank: 24%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/24/2026 | RBC Capital | Trung Huynh | New Coverage | Sector Perform (N/A) |
60.00 (N/A) |
61.25 (57.13) |
-6.73% | Details |
| 2/19/2026 | Barclays | Brandon Oglenski | New Coverage | Overweight (N/A) |
75.00 (N/A) |
59.73 (57.13) |
-4.35% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
